Reference is made to the stock exchange notice dated 8 April 2014
regarding the private placement completed on 7 April 2014.
The share capital increase approved by the Board in accordance with the
authorization granted by the General Meeting has been registered in the
Norwegian Register of Business Enterprises and the new shares have been
issued in VPS. The new registered share capital of Biotec Pharmacon ASA
is NOK 43 293 173 divided into NOK 43 293 173 shares each with a par
value of NOK 1.